Evidence map›Paper›PMID 40604157›Full record

ArticleNature metabolism2025

Retraction Note: Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice.

Lingfeng Shi, Yixiang Li, Xiaoli Xu, Yangyang Cheng, Biying Meng, Jinling Xu, Lin Xiang, Jiajia Zhang, Kaiyue He, Jiayue Tong and 3 more

Abstract readRetraction Notice
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Lingfeng ShiDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Yixiang LiDepartment of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA, USA.
Xiaoli XuDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Yangyang ChengDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Biying MengDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Jinling XuThe First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Lin XiangDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Jiajia ZhangDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
Kaiyue HeThe First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Jiayue TongThe First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Junxia ZhangDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China. Zhangjx023@163.com.
Lingwei XiangCenters for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA. Lxiang2@bwh.harvard.edu.
Guangda XiangDepartment of Endocrinology, General Hospital of Central Theater Command, Wuhan, China. Guangda64@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40604157
PMCPMC12286837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.